CD26 and Asthma: a Comprehensive Review

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2016 Aug 27

PMID 27561663

Citations 19

Authors

Juan J Nieto-Fontarigo

Francisco J Gonzalez-Barcala

Esther San Jose

Pilar Arias

Montserrat Nogueira

Francisco J Salgado

Affiliations

Soon will be listed here.

Abstract

Asthma is a heterogeneous and chronic inflammatory family of disorders of the airways with increasing prevalence that results in recurrent and reversible bronchial obstruction and expiratory airflow limitation. These diseases arise from the interaction between environmental and genetic factors, which collaborate to cause increased susceptibility and severity. Many asthma susceptibility genes are linked to the immune system or encode enzymes like metalloproteases (e.g., ADAM-33) or serine proteases. The S9 family of serine proteases (prolyl oligopeptidases) is capable to process peptide bonds adjacent to proline, a kind of cleavage-resistant peptide bonds present in many growth factors, chemokines or cytokines that are important for asthma. Curiously, two serine proteases within the S9 family encoded by genes located on chromosome 2 appear to have a role in asthma: CD26/dipeptidyl peptidase 4 (DPP4) and DPP10. The aim of this review is to summarize the current knowledge about CD26 and to provide a structured overview of the numerous functions and implications that this versatile enzyme could have in this disease, especially after the detection of some secondary effects (e.g., viral nasopharyngitis) in type II diabetes mellitus patients (a subset with a certain risk of developing obesity-related asthma) upon CD26 inhibitory therapy.

Citing Articles

Urinary Proteome and Exosome Analysis Protocol for the Discovery of Respiratory Diseases Biomarkers.

Martelo-Vidal L, Vazquez-Mera S, Miguens-Suarez P, Bravo-Lopez S, Makrinioti H, Dominguez-Arca V Biomolecules. 2025; 15(1).

PMID: 39858454 PMC: 11762655. DOI: 10.3390/biom15010060.

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases.

Guo D, Liu Z, Zhou J, Ke C, Li D Int J Mol Sci. 2024; 25(18).

PMID: 39337436 PMC: 11432010. DOI: 10.3390/ijms25189947.

Development of the dipeptidyl peptidase 4 family and its association with lung diseases: a narrative review.

Hua E, Xu D, Chen H, Zhang S, Feng J, Xu L J Thorac Dis. 2024; 15(12):7024-7034.

PMID: 38249892 PMC: 10797411. DOI: 10.21037/jtd-23-1158.

Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study.

Huang K, Li F, Wang X, Yan B, Wang M, Li S Respir Res. 2022; 23(1):119.

PMID: 35546400 PMC: 9092818. DOI: 10.1186/s12931-022-02028-3.

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence.

Zhang T, Tong X, Zhang S, Wang D, Wang L, Wang Q Front Pharmacol. 2021; 12:731453.

PMID: 34955820 PMC: 8696080. DOI: 10.3389/fphar.2021.731453.

References

Bauvois B, De Meester I, Dumont J, Rouillard D, Zhao H, Bosmans E . Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. Br J Cancer. 1999; 79(7-8):1042-8. PMC: 2362248. DOI: 10.1038/sj.bjc.6690167. View

Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts J . CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol. 1999; 162(8):4903-9. View

van der Velden V, Hulsmann A . Peptidases: structure, function and modulation of peptide-mediated effects in the human lung. Clin Exp Allergy. 1999; 29(4):445-56. PMC: 7162142. DOI: 10.1046/j.1365-2222.1999.00462.x. View

Iwata S, Yamaguchi N, Munakata Y, Ikushima H, Lee J, Hosono O . CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int Immunol. 1999; 11(3):417-26. DOI: 10.1093/intimm/11.3.417. View

van der Velden V, Naber B, van Hal P, Overbeek S, Hoogsteden H, Versnel M . Peptidase activities in serum and bronchoalveolar lavage fluid from allergic asthmatics--comparison with healthy non-smokers and smokers and effects of inhaled glucocorticoids. Clin Exp Allergy. 1999; 29(6):813-23. DOI: 10.1046/j.1365-2222.1999.00550.x. View

Kahne T, Lendeckel U, Wrenger S, Neubert K, Ansorge S, Reinhold D . Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). Int J Mol Med. 1999; 4(1):3-15. DOI: 10.3892/ijmm.4.1.3. View

Wesley U, Albino A, Tiwari S, Houghton A . A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med. 1999; 190(3):311-22. PMC: 2195594. DOI: 10.1084/jem.190.3.311. View

De Meester I, Korom S, Van Damme J, Scharpe S . CD26, let it cut or cut it down. Immunol Today. 1999; 20(8):367-75. DOI: 10.1016/s0167-5699(99)01486-3. View

Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D . The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. J Clin Invest. 1999; 104(4):R1-5. PMC: 481049. DOI: 10.1172/JCI7318. View

10.

Mentlein R . Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides. Regul Pept. 1999; 85(1):9-24. DOI: 10.1016/s0167-0115(99)00089-0. View

11.

Bauvois B, Djavaheri-Mergny M, Rouillard D, Dumont J, Wietzerbin J . Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene. 2000; 19(2):265-72. DOI: 10.1038/sj.onc.1203292. View

12.

Ohtsuki T, Tsuda H, Morimoto C . Good or evil: CD26 and HIV infection. J Dermatol Sci. 2000; 22(3):152-60. DOI: 10.1016/s0923-1811(99)00081-x. View

13.

Rogge L, Bianchi E, Biffi M, Bono E, Chang S, Alexander H . Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet. 2000; 25(1):96-101. DOI: 10.1038/75671. View

14.

Huhn J, Ehrlich S, Fleischer B, von Bonin A . Molecular analysis of CD26-mediated signal transduction in T cells. Immunol Lett. 2000; 72(2):127-32. DOI: 10.1016/s0165-2478(00)00170-x. View

15.

Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L . Dipeptidyl peptidase IV in inflammatory CNS disease. Adv Exp Med Biol. 2000; 477:145-53. DOI: 10.1007/0-306-46826-3_16. View

16.

Gonzalo J, Lloyd C, Peled A, Delaney T, Coyle A, Gutierrez-Ramos J . Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1 alpha in the inflammatory component of allergic airway disease. J Immunol. 2000; 165(1):499-508. DOI: 10.4049/jimmunol.165.1.499. View

17.

Salgado F, Vela E, Martin M, Franco R, Nogueira M, Cordero O . Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes. Cytokine. 2000; 12(7):1136-41. DOI: 10.1006/cyto.1999.0643. View

18.

Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H . Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci U S A. 2000; 97(15):8439-44. PMC: 26966. DOI: 10.1073/pnas.97.15.8439. View

19.

De Marco R, Locatelli F, Sunyer J, Burney P . Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med. 2000; 162(1):68-74. DOI: 10.1164/ajrccm.162.1.9907008. View

20.

Arndt M, Lendeckel U, Spiess A, Faust J, Neubert K, Reinhold D . Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1). Biochem Biophys Res Commun. 2000; 274(2):410-4. DOI: 10.1006/bbrc.2000.3144. View